High affinity human antibodies to human IL-4 receptor

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000, C530S387100, C530S387300

Reexamination Certificate

active

07608693

ABSTRACT:
An isolated human antibody or antibody fragment thereof which binds to human interleukin-4 receptor alpha (hIL-4Rα) with high affinity (KD), capable of blocking hIL-4 and hIL-13 activity.

REFERENCES:
patent: 5714146 (1998-02-01), Lewis
patent: 5717072 (1998-02-01), Mosley
patent: 5985280 (1999-11-01), Ritter
patent: 6716587 (2004-04-01), Mosley
patent: 7186809 (2007-03-01), Pluenneke
patent: 2005/0282181 (2005-12-01), Yan et al.
patent: 2007/0041976 (2007-02-01), Pluenneke
patent: 0 604 693 (1994-07-01), None
patent: WO 01/92340 (2001-12-01), None
patent: WO 2005/047331 (2005-05-01), None
patent: WO 2006/072564 (2006-07-01), None
Zurawski, SM et al. 1995 The primary binding subunit of the human Interleukin-4 receptor is also a component of the Interleukin-13 receptor. J. of Biol. Chem. Am. Society of Biolochemical Biologists. 270(23): 13869-13878.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

High affinity human antibodies to human IL-4 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High affinity human antibodies to human IL-4 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High affinity human antibodies to human IL-4 receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4137472

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.